首页> 外文期刊>Cell death and differentiation >A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency
【24h】

A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency

机译:一系列Fas受体激动剂抗体,显示亲和力和效能之间呈负相关

获取原文
获取原文并翻译 | 示例
           

摘要

Receptor agonism remains poorly understood at the molecular and mechanistic level. In this study, we identified a fully human anti-Fas antibody that could efficiently trigger apoptosis and therefore function as a potent agonist. Protein engineering and crystallography were used to mechanistically understand the agonistic activity of the antibody. The crystal structure of the complex was determined at 1.9 ? resolution and provided insights into epitope recognition and comparisons with the natural ligand FasL (Fas ligand). When we affinity-matured the agonist antibody, we observed that, surprisingly, the higher-affinity antibodies demonstrated a significant reduction, rather than an increase, in agonist activity at the Fas receptor. We propose and experimentally demonstrate a model to explain this non-intuitive impact of affinity on agonist antibody signalling and explore the implications for the discovery of therapeutic agonists in general.
机译:受体激动剂在分子和机制水平上仍知之甚少。在这项研究中,我们确定了一个完整的人类抗Fas抗体,可以有效触发细胞凋亡,因此可以作为有效的激动剂。蛋白工程和晶体学被用来机械地理解抗体的激动活性。配合物的晶体结构确定为1.9≤m。分辨率,并为表位识别和与天然配体FasL(Fas配体)的比较提供了见解。当我们对激动剂抗体进行亲和力成熟时,我们惊讶地观察到,亲和力更高的抗体表现出对Fas受体的激动剂活性显着降低而不是增加。我们提出并通过实验证明了一个模型来解释这种亲和力对激动剂抗体信号传导的非直观影响,并探索了一般发现治疗性激动剂的意义。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号